Le Lézard
Classified in: Science and technology, Business
Subjects: EARNINGS, Conference, Trade Show, Conference Call, Webcast, Advisory

Arista Networks to Announce Q1 2020 Financial Results on Tuesday, May 5th 2020


Arista Networks, Inc. (NYSE:ANET) will release its financial results for the quarter ended March 31, 2020 after U.S. markets close on Tuesday, May 5th, 2020. The results will be included in a press release with accompanying financial information that will be posted on the Investor Relations section of the Arista website at https://investors.arista.com.

Arista's executive management team will host a conference call on May 5th, beginning at 1:30 p.m. PT (4:30 p.m. ET) to discuss financial results and business highlights. Interested parties may access the call by dialing (833) 287-7905 in the United States or (647) 689-4469 from international locations. The Conference ID is 9769576. Please dial-in ten minutes prior to the scheduled conference call time. In addition, a live webcast of the conference call will be accessible from the Investor Relations section of the Arista website at https://investors.arista.com.

Shortly after the conclusion of the conference call, a replay of the audio webcast will be available on Arista's Investor Relations website.

Upcoming Investor Event Participation

Arista also announces it will participate in the following virtual events in May and June with the financial community:

J.P. Morgan Global Technology, Media and Communications Conference
Ita Brennan, CFO
May 12-14, 2020
Date & Time: TBD on the Investor Relations section of the Arista website.

BofA 2020 Global Technology Conference
John McCool, Chief Platform Officer
June 2-4, 2020
Date & Time: TBD on the Investor Relations section of the Arista website.

William Blair 40th Annual Growth Stock Conference
Anshul Sadana, COO
June 9-11, 2020
Date & Time: TBD on the Investor Relations section of the Arista website.

A live audio webcast of these events will be accessible from the Investor Relations section of the Arista website at https://investors.arista.com.

About Arista Networks

Arista Networks pioneered software-driven, cognitive cloud networking for large-scale datacenter and campus environments. Arista's award-winning platforms redefine and deliver availability, agility, automation, analytics, and security. Arista has shipped more than twenty million cloud networking ports worldwide with CloudVision and EOS, an advanced network operating system. Committed to open standards across private, public and hybrid cloud solutions, Arista products are supported worldwide directly and through partners.

Additional information and resources can be found at: https://www.arista.com


These press releases may also interest you

at 07:44
Killi Ltd. (the "Company") , a global leader in consumer privacy, today announced the integration of access to over 20,000 financial institutions into its product. The inclusion of core financial firms allows consumers to opt in and put their...

at 07:38
1901 Group today announced that Steve Hamric has been appointed as Chief Financial Officer (CFO). Hamric has over 20 years' experience leading finance and account organizations across a variety of industries. Hamric most recently served as the CFO of...

at 07:35
Titan Medical Inc. ("Titan" or "Titan Medical") , a medical device company focused on the design and development of single-port robotic surgical technologies, announces that it has entered into a development and license agreement with Medtronic plc...

at 07:35
Financial services organizations of all sizes must remain one step ahead of financial crime. To enable this NICE Actimize a leader in Autonomous Financial Crime Management, announces that it has entered a definitive agreement to acquire Guardian...

at 07:35
NexTech AR Solutions (the "Company" or "NexTech") , an emerging leader in augmented reality for eCommerce, AR learning applications, and virtual events is pleased to announce the launch of its new ARitize360 app now live and available for a FREE...

at 07:35
Full analysis of the CLE part of the LILAC study reinforces positive top-line results; participants who received BIIB059 (anti-BDCA2) demonstrated statistically significant reduction of disease activity compared to those who received placeboSafety...



News published on 7 april 2020 at 16:05 and distributed by: